UK’s Oxford University COVID-19 Vaccine Shows Promising Results

The human trials of the Coronavirus vaccine developed by Oxford University in Britain have shown positive results.
Image credit: ANI News
Image credit: ANI News
Updated on

The human trials of the Coronavirus vaccine developed by Oxford University in Britain have shown positive results and found safe for the human body. During the human trials, scientists found that this vaccine has developed immunity in the human body to fight the coronavirus.

The human trial of this vaccine included 1077 people. People developed white blood cells and antibodies in their bodies. Scientists at Oxford University are excited by the results of the Human Trial. They say that after this success, they will confirm the vaccine's effectiveness by doing a large scale human trial. According to the report, the UK government has already placed an order to produce 100 million doses of this vaccine.

Development of vaccine:

Oxford University has developed this ChAdOx1 nCoV-19 vaccine rapidly. According to the report, it has been prepared with the help of genetically engineered viruses. The vaccine has been prepared by introducing genetic changes in this virus. It has been changed in such a way that it cannot infect people and can create the ability to fight the coronavirus.

Image credit: ANI News
Image credit: ANI News

Vaccine is safe but also has minor side effects:

According to the report, the vaccine is completely safe but it also has some minor side-effects. These are not harmful, but are minor. 70 percent of people have complained about some side effects such as fever and headache after taking the dose of this vaccine. However, according to the researchers, these problems can be overcome with common medicines like paracetamol.

Vaccine is effective against the coronavirus: Sarah Gilbert

Oxford University professor Sarah Gilbert says the vaccine is effective against the coronavirus. In a research published in the prestigious health journal Lancet on Monday, scientists said that the vaccine caused a double immune response in people aged 18 to 55 years.

Like and Follow us on :

Related Stories

No stories found.
logo
Since independence
www.sinceindependence.com